Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Foundation for Research in Genetics and Endocrinology, |
RCV000761558 | SCV000889930 | pathogenic | Sandhoff disease | 2019-03-12 | criteria provided, single submitter | clinical testing | The R100X variant in the HEXB gene has been reported in 2 Indian patients with autosomal recessive Sandhoff disease (Tamhankar et al 2015) and is absent in the gnomAD database. Furthermore, nonsense mutations affecting HEXB gene is a known disease mechanism for Sandhoff disease and the R100X variant has been predicted to be pathogenic in silico by DANN, GERP, LRT and MutationTaster. In summary, the R100X variant meets the ACMG criteria to be classified as pathogenic based upon literature, absence from controls and computational evidence. |
Baylor Genetics | RCV000761558 | SCV001162988 | pathogenic | Sandhoff disease | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000761558 | SCV003525921 | pathogenic | Sandhoff disease | 2022-02-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg100*) in the HEXB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HEXB are known to be pathogenic (PMID: 7550345, 18758829). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Sandhoff disease (PMID: 26582265). ClinVar contains an entry for this variant (Variation ID: 623479). For these reasons, this variant has been classified as Pathogenic. |